Literature DB >> 15936558

Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients.

Tae Hyun Kim1, Eui Kyu Chie, Dae Yong Kim, Sung Yong Park, Kwan Ho Cho, Kyung Hae Jung, Young Hoon Kim, Dae Kyung Sohn, Seung-Yong Jeong, Jae-Gahb Park.   

Abstract

PURPOSE: To determine the most effective method to reduce the irradiated small bowel volume when using a belly board device (BBD), a distended bladder (DB), or both in patients with rectal cancer undergoing preoperative pelvic radiotherapy (RT). METHODS AND MATERIALS: The study involved 20 patients with rectal cancer who were scheduled to receive preoperative pelvic RT. Patients were asked to empty their bladders and then drink 300 mL of water 2 h before the treatment planning computed tomographic (CT) scan. To identify the small bowel, an oral contrast solution (450 mL) was given 1 h before the CT scan. Two sets of transverse images were taken at 1-cm-thickness intervals with patients in the prone position with or without the BBD. After voiding, two additional sets of CT scans were obtained in prone positions with or without BBD. The conventional three-field treatment plan, composed of a 6-MV photon posterior-anterior field and 15-MV photon opposed lateral fields with wedges of 45 degrees, was made using a three-dimensional treatment planning system. The beam weights of the three-field plan were equal. The volume of irradiated small bowel was calculated for doses between 10% and 100% of the prescribed dose at 10% intervals. For each 10% dose increment, the effect of the BBD and the DB on the irradiated volume was analyzed using Kruskal-Wallis, Wilcoxon signed rank, and Wilcoxon rank-sum tests.
RESULTS: All patients underwent four sets of CT scan under the conditions of four different methods as follows: Group I = empty bladder without the use of belly board; Group II = empty bladder with the use of belly board; Group III = distended bladder without the use of belly board; Group IV = distended bladder with the use of belly board. We found that the volume of irradiated small bowel decreased in the order of Group I, Group II, Group III, and Group IV at all dose levels (p < 0.05). Compared with Group I, the mean volume reduction rate (reduced volume) of irradiated small bowel in Group II varied between 14.5% and 65.4% (15.5-80.4 cm(3)), in Group III it varied between 48.1% and 82.0% (21.6-163.1 cm(3)), and in Group IV between 51.4% and 96.4% (28.6-167.1 cm(3)).
CONCLUSIONS: The DB was more effective than the BBD for reducing the volume of irradiated small bowel in rectal cancer patients receiving pelvic RT. The combination of the BBD and DB showed an additive effect and was the most effective method for reducing the irradiated small bowel volume.

Entities:  

Mesh:

Year:  2005        PMID: 15936558     DOI: 10.1016/j.ijrobp.2004.11.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Intensity-modulated radiotherapy with a belly board for rectal cancer.

Authors:  Joo Young Kim; Dae Yong Kim; Tae Hyun Kim; Sung Yong Park; Se Byeong Lee; Kyung Hwan Shin; Hongryull Pyo; Joo-Young Kim; Kwan Ho Cho
Journal:  Int J Colorectal Dis       Date:  2006-06-27       Impact factor: 2.571

2.  A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma : Comparison of 3‑dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy.

Authors:  Sergiu Scobioala; Christopher Kittel; Philipp Niermann; Heidi Wolters; Katharina Helene Susek; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2018-05-31       Impact factor: 3.621

Review 3.  Quality Control of Radiation Delivery for Lower Gastrointestinal Cancers.

Authors:  Supriya Jain; Karyn A Goodman
Journal:  Curr Treat Options Oncol       Date:  2018-09-07

Review 4.  Technical aspects of radiation therapy for anal cancer.

Authors:  Eli D Scher; Inaya Ahmed; Ning J Yue; Salma K Jabbour
Journal:  J Gastrointest Oncol       Date:  2014-06

5.  Small bowel protection in IMRT for rectal cancer : A dosimetric study on supine vs. prone position.

Authors:  Julia Koeck; Katharina Kromer; Frank Lohr; Tobias Baack; Kerstin Siebenlist; Sabine Mai; Sylvia Büttner; Jens Fleckenstein; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2017-02-20       Impact factor: 3.621

6.  Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer.

Authors:  Naoki Nakamura; Naoto Shikama; Osamu Takahashi; Makiko Ito; Masatoshi Hashimoto; Masahiro Uematsu; Yukihiro Hama; Kenji Sekiguchi; Keiichi Nakagawa
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

7.  Compliance with bladder protocol during concurrent chemoradiation for cancer of the cervix and its impact on enteritis: A prospective observational study.

Authors:  Sweta Bandanatham; Janaki Manur Gururajachar; Mohan Kumar Somashekar
Journal:  Rep Pract Oncol Radiother       Date:  2018-02-02

8.  Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner.

Authors:  Jee Suk Chang; Hong In Yoon; Hye Jung Cha; Yoonsun Chung; Yeona Cho; Ki Chang Keum; Woong Sub Koom
Journal:  Radiat Oncol J       Date:  2013-03-31

9.  Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits.

Authors:  Salma K Jabbour; Shyamal Patel; Joseph M Herman; Aaron Wild; Suneel N Nagda; Taghrid Altoos; Ahmet Tunceroglu; Nilofer Azad; Susan Gearheart; Rebecca A Moss; Elizabeth Poplin; Lydia L Levinson; Ravi A Chandra; Dirk F Moore; Chunxia Chen; Bruce G Haffty; Richard Tuli
Journal:  Int J Surg Oncol       Date:  2012-08-13

10.  ACR appropriateness criteria®  resectable rectal cancer.

Authors:  William E Jones; Charles R Thomas; Joseph M Herman; May Abdel-Wahab; Nilofer Azad; William Blackstock; Prajnan Das; Karyn A Goodman; Theodore S Hong; Salma K Jabbour; Andre A Konski; Albert C Koong; Miguel Rodriguez-Bigas; William Small; Jennifer Zook; W Warren Suh
Journal:  Radiat Oncol       Date:  2012-09-24       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.